This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow [Français]
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kapral, M. K.
Right arrow Articles by Silver, F. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kapral, M. K.
Right arrow Articles by Silver, F. L.
Related Collections
Right arrow Clinical Practice Guidelines
CMAJ • October 19, 1999; 161 (8)
© 1999 Canadian Medical Association or its licensors


Education
Éducation

Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke

Moira K. Kapral, MD*{dagger}, Frank L. Silver, MD*{ddagger} and With the Canadian Task Force on Preventive Health Care§

From *the Department of Medicine, University of Toronto, Toronto, Ont., and the Divisions of {dagger}General Internal Medicine and Clinical Epidemiology and of {ddagger}Neurology, University Health Network, Toronto, Ont.

Abstract

Objective: To develop guidelines for the use of echocardiography in the investigation of patients with stroke.

Options: (1) Routine transthoracic echocardiography (TTE); (2) routine transesophageal echocardiography (TEE); (3) routine TTE followed by TEE if the TTE findings are noncontributory; (4) selective TTE or TEE in patients with cardiac disease who would not otherwise receive anticoagulant therapy.

Outcomes: This article reviews the available evidence on the yield of TTE and TEE in detecting cardiac sources of cerebral emboli in patients with stroke, the effectiveness of treatment for cardiac sources of emboli and the effectiveness of screening echocardiography for secondary stroke prevention.

Evidence: MEDLINE was searched for relevant articles published from January 1966 to April 1998; also reviewed were additional articles identified from the bibliographies and citations obtained from experts.

Benefits, harms and costs: Echocardiography can detect intracardiac masses (thrombus, vegetation or tumour) in about 4% (with TTE) to 11% (with TEE) of stroke patients. The yield is lower among patients without clinical evidence of cardiac disease by history, physical examination, electrocardiography or chest radiography (less than 2%) than among patients with clinical evidence of cardiac disease (less than 19%). The risks of echocardiography to patients are small. TTE has virtually no risks, and TEE is associated with cardiac, pulmonary and bleeding complications in 0.18%. Patients with an identified intracardiac thrombus are at increased risk for embolic events (absolute risk uncertain, range 0%-38%), and this appears to be reduced with anticoagulant therapy (absolute risk reduction uncertain). Anticoagulant therapy carries a risk of major hemorrhage of 1% to 3% per year. The overall effectiveness of echocardiography in the prevention of recurrent stroke is unknown.

Values: The strength of evidence was evaluated using the methods of the Canadian Task Force on Preventive Health Care.

Recommendations: There is fair evidence to recommend echocardiography in patients with stroke and clinical evidence of cardiac disease by history, physical examination, electrocardiography or chest radiography (grade B recommendation). There is insufficient evidence to recommend for or against TEE in patients with normal results of TTE (grade C recommendation). There is insufficient evidence to recommend for or against routine echocardiography in patients (including young patients) without clinical cardiac disease (grade C recommendation). Routine echocardiography is not recommended for patients with clinical cardiac disease who have independent indications for or contraindications to anticoagulant therapy (grade D recommendation). There is fair evidence to recommend anticoagulant therapy in patients with stroke and intracardiac thrombus (grade B recommendation). There is insufficient (no) evidence to recommend for or against any specific therapy for patent foramen ovale (grade C recommendation).

Validation: The findings of this analysis were reviewed through an iterative process by the members of the Canadian Task Force on Preventive Health Care.

Sponsors: The Canadian Task Force on Preventive Health Care is funded through a partnership between the Provincial and Territorial Ministries of Health and Health Canada.





This article has been cited by other articles:


Home page
Eur J EchocardiogrHome page
S. Maffe, P. Dellavesa, F. Zenone, A. M. Paino, P. Paffoni, A. Perucca, D. Kozel, F. Signorotti, M. Bielli, U. Parravicini, et al.
Transthoracic second harmonic two- and three-dimensional echocardiography for detection of patent foramen ovale
Eur J Echocardiogr, November 12, 2009; (2009) jep165v1.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. G. Morris, E. J. Duffis, and M. Fisher
Cardiac Workup of Ischemic Stroke: Can We Improve Our Diagnostic Yield?
Stroke, August 1, 2009; 40(8): 2893 - 2898.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Hur, Y. J. Kim, H.-J. Lee, J.-W. Ha, J. H. Heo, E.-Y. Choi, C.-Y. Shim, T. H. Kim, J. E. Nam, K. O. Choe, et al.
Cardiac Computed Tomographic Angiography for Detection of Cardiac Sources of Embolism in Stroke Patients
Stroke, June 1, 2009; 40(6): 2073 - 2078.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
C. B Josephson, R. A.-S. Salman, and S. J Phillips
An episode of transient neurological symptoms
BMJ, February 25, 2009; 338(feb25_2): b616 - b616.
[Full Text]


Home page
StrokeHome page
S. F.T.M. de Bruijn, W. R.P. Agema, G. J. Lammers, E. E. van der Wall, R. Wolterbeek, E. R. Holman, E. L.E.M. Bollen, and J. J. Bax
Transesophageal Echocardiography Is Superior to Transthoracic Echocardiography in Management of Patients of Any Age With Transient Ischemic Attack or Stroke
Stroke, October 1, 2006; 37(10): 2531 - 2534.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Y. Beaulieu and P. E. Marik
Bedside Ultrasonography in the ICU: Part 2
Chest, September 1, 2005; 128(3): 1766 - 1781.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
K. D. Flemming, R. D. Brown Jr, G. W. Petty, J. Huston III, D. F. Kallmes, and D. G. Piepgras
Evaluation and Management of Transient Ischemic Attack and Minor Cerebral Infarction
Mayo Clin. Proc., August 1, 2004; 79(8): 1071 - 1086.
[Abstract] [PDF]


Home page
CMAJHome page
F. O'Rourke, N. Dean, M. S. Mouradian, N. Akhtar, and A. Shuaib
Atrial myxoma as a cause of stroke: case report and discussion
Can. Med. Assoc. J., November 11, 2003; 169(10): 1049 - 1051.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. J. PROVENCIO, T. P. BLECK, and A. F. CONNORS Jr.
Critical Care Neurology
Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 341 - 345.
[Full Text] [PDF]


Home page
Evid. Based Med.Home page
Additional articles abstracted in ACP Journal Club
Evid. Based Med., May 1, 2000; 5(3): 67 - 67.
[Full Text]


Home page
CMAJHome page
C. R. Thompson
Echocardiography in stroke: Which probe when?
Can. Med. Assoc. J., October 1, 1999; 161(8): 981 - 982.
[Full Text] [PDF]